- Release Date: 08/04/24 08:57
- Summary: SYNThesis BioVentures MoU for cellular immunotherapies
- Price Sensitive: Yes
- Download Document 211.2KB
Ann: SYNThesis BioVentures MoU for cellular immunotherapies
- There are more pages in this discussion • 125 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add 1AD (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.5¢ |
Change
0.001(4.17%) |
Mkt cap ! $13.32M | |||
| Open | High | Low | Value | Volume |
| 2.5¢ | 2.7¢ | 2.5¢ | $48.90K | 1.864M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 312000 | 2.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.6¢ | 71000 | 1 |
View Market Depth
| Last trade - 13.43pm 21/05/2024 (20 minute delay) ? |
|
|||||
|
Last
2.5¢ |
Change
0.001 ( 4.17 %) |
||||
| Open | High | Low | Volume | ||
| 2.5¢ | 2.7¢ | 2.4¢ | 496956 | ||
| Last updated 13.43pm 21/05/2024 ? | |||||
| 1AD (ASX) Chart |